Invited as presenter at the Immunotherapies & Innovations for Infectious Diseases Congress (#I4ID2025) – in Lyon, CEO of Inicure Peter Olofsson-Sahl presetnerd our lates progress, including lead optimisation running at #ScilifeLAB.

This was a great opportunity to update contacts with some of our future R&D partners, and listen to the support provided by CARB-X, Incate and the ID cluster and the listen to updates on the increasing problem with AMR, lack of effective therapies and urge for novel actions and therapies to combat the progression of the global number One medical threat of increasing antibiotic resistance